Remove 2022 Remove DEA Remove Policy
article thumbnail

Intoxicating Hemp Swindle

Project CBD

In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary. Yet its advocates tout its ability to help wean users off opioids.

article thumbnail

Marijuana to Schedule III is Necessary, But Let’s Be Honest About Its Limits

Canna Law Blog

And according to DEA, no one has died from a marijuana overdose. The Research Act reinforces Schedule I treatment Passed in 2022, the Research Act was hailed by policymakers as a breakthrough for marijuana research. 823(c)(1), DEA-registered bulk manufacturers can provide marijuana only to researchers with Schedule I registration.

DEA
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Americans Will Cultivate Over 4 Billion Grams Of Homegrown Cannabis in 2022

Veriheal

As of July 2022, 38 states in America have legalized medical cannabis, and 19 states and the District of Columbia have established recreational cannabis programs. Those three million home growers are expected to cultivate approximately 11 million pounds of dried cannabis in 2022. Cultivation Costs for Homegrowers.

article thumbnail

Canopy Growth Reports First Quarter Fiscal 2022 Financial Results – The John Bonham Of Cannabis?

Cannabis Law Report

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

article thumbnail

Is The DEA Poised To Regulate Telepharmacy?

Cannabis Law Report

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA
article thumbnail

CBD Lawsuit Reflects Trucker Termination for THC Tainted Drug Products

The Blunt Truth

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% We had previously blogged on The Stoned Age: What the CBD Craze Means for Employers and Their Substance Abuse Policies , CBD is Everywhere – But Where Does the FDA Stand?

THC
article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.